Traditional Dietary Advice, Low FODMAP Diet, or Gluten-Free Diet for IBS: Growing Understanding but Uncertainties Remain

Heidi M. Staudacher; Peter R. Gibson

doi:10.1016/j.cgh.2022.05.051

Traditional Dietary Advice, Low FODMAP Diet, or Gluten-Free Diet for IBS: Growing Understanding but Uncertainties Remain

Heidi M. Staudacher, Peter R. Gibson

Gastroenterology

Research output: Contribution to journal › Letter › Other › peer-review

2 Citations (Scopus)

Original language	English
Number of pages	2
Journal	Clinical Gastroenterology and Hepatology
DOIs	https://doi.org/10.1016/j.cgh.2022.05.051
Publication status	Accepted/In press - 9 Jul 2022

Access to Document

10.1016/j.cgh.2022.05.051

Cite this

@article{8d97ec6687e44dce97b9ffa1276a987d,

title = "Traditional Dietary Advice, Low FODMAP Diet, or Gluten-Free Diet for IBS: Growing Understanding but Uncertainties Remain",

author = "Staudacher, {Heidi M.} and Gibson, {Peter R.}",

note = "Funding Information: Conflicts of interest This author discloses the following: Peter R. Gibson has served as a consultant or advisory board member for Anatara, Atmo Biosciences, Immunic Therapeutics, Novozymes, Novoviah, and Comvita; has received research grants for investigator-driven studies from Atmo Biosciences; and holds shares in Atmo Biosciences. His department financially benefits from the sales of a digital application, booklets, and online courses on the FODMAP diet. Heidi M. Staudacher discloses no conflicts.",

year = "2022",

month = jul,

day = "9",

doi = "10.1016/j.cgh.2022.05.051",

language = "English",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "Elsevier",

}

TY - JOUR

T1 - Traditional Dietary Advice, Low FODMAP Diet, or Gluten-Free Diet for IBS

T2 - Growing Understanding but Uncertainties Remain

AU - Staudacher, Heidi M.

AU - Gibson, Peter R.

N1 - Funding Information: Conflicts of interest This author discloses the following: Peter R. Gibson has served as a consultant or advisory board member for Anatara, Atmo Biosciences, Immunic Therapeutics, Novozymes, Novoviah, and Comvita; has received research grants for investigator-driven studies from Atmo Biosciences; and holds shares in Atmo Biosciences. His department financially benefits from the sales of a digital application, booklets, and online courses on the FODMAP diet. Heidi M. Staudacher discloses no conflicts.

PY - 2022/7/9

Y1 - 2022/7/9

UR - http://www.scopus.com/inward/record.url?scp=85136551641&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2022.05.051

DO - 10.1016/j.cgh.2022.05.051

M3 - Letter

C2 - 35820562

AN - SCOPUS:85136551641

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

ER -

Traditional Dietary Advice, Low FODMAP Diet, or Gluten-Free Diet for IBS: Growing Understanding but Uncertainties Remain

Access to Document

Other files and links

Cite this